CDK2 and hepatocellular carcinoma: In terms of cancer transformative potential, analysis in rat embryonic fibroblasts has also suggested that this property of cyclin E may, in certain circumstances, be independent of CDK2 [234], an observation that is also consistent with analyses conducted in hepatocellular carcinoma (HCC) [233].